Obtaining evidence base for the development of Feel4Diabetes intervention to prevent type 2 diabetes - a narrative literature review.
Families
Lifestyle intervention
Prevention
Risk factors
Type 2 diabetes
Vulnerable
Journal
BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676
Informations de publication
Date de publication:
12 Mar 2020
12 Mar 2020
Historique:
received:
28
11
2019
accepted:
04
12
2019
entrez:
14
3
2020
pubmed:
14
3
2020
medline:
27
11
2020
Statut:
epublish
Résumé
Feel4Diabetes was a school and community based intervention aiming to promote healthy lifestyle and tackle obesity for the prevention of type 2 diabetes among families in 6 European countries. We conducted this literature review in order to guide the development of evidence-based implementation of the Feel4Diabetes intervention. We focused on type 2 diabetes prevention strategies, including all the phases from risk identification to implementation and maintenance. Special focus was given to prevention among vulnerable groups and people under 45 years. Scientific and grey literature published between January 2000 and January 2015 was searched for relevant studies using electronic databases. To present the literature review findings in a systematic way, we used the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. A complementary literature search from February 2015 to December 2018 was also conducted. The initial review included 27 studies with a follow-up ≥12 months and 9 studies with a follow-up ≥6 months and with a participant mean age < 45 years. We found out that interventions should be targeted at people at risk to improve recruiting and intervention effectiveness. Screening questionnaires (primarily Finnish Diabetes Risk Score FINDRISC) and blood glucose measurement can both be used for screening; the method does not appear to affect intervention effectiveness. Screening and recruitment is time-consuming, especially when targeting lower socioeconomic status and age under 45 years. The intervention intensity is more important for effectiveness than the mode of delivery. Moderate changes in several lifestyle habits lead to good intervention results. A minimum of 3-year follow-up seemed to be required to show a reduction in diabetes risk in high-risk individuals. In participants < 45 years, the achieved results in outcomes were less pronounced. The complementary review included 12 studies, with similar results regarding intervention targets and delivery modes, as well as clinical significance. This narrative review highlighted several important aspects that subsequently guided the development of the Feel4Diabetes high-risk intervention. Research on diabetes prevention interventions targeted at younger adults or vulnerable population groups is still relatively scarce. Feel4Diabetes is a good example of a project aiming to fill this research gap. clinicaltrials.gov NCT02393872, registered 20th March 2015.
Sections du résumé
BACKGROUND
BACKGROUND
Feel4Diabetes was a school and community based intervention aiming to promote healthy lifestyle and tackle obesity for the prevention of type 2 diabetes among families in 6 European countries. We conducted this literature review in order to guide the development of evidence-based implementation of the Feel4Diabetes intervention. We focused on type 2 diabetes prevention strategies, including all the phases from risk identification to implementation and maintenance. Special focus was given to prevention among vulnerable groups and people under 45 years.
METHODS
METHODS
Scientific and grey literature published between January 2000 and January 2015 was searched for relevant studies using electronic databases. To present the literature review findings in a systematic way, we used the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. A complementary literature search from February 2015 to December 2018 was also conducted.
RESULTS
RESULTS
The initial review included 27 studies with a follow-up ≥12 months and 9 studies with a follow-up ≥6 months and with a participant mean age < 45 years. We found out that interventions should be targeted at people at risk to improve recruiting and intervention effectiveness. Screening questionnaires (primarily Finnish Diabetes Risk Score FINDRISC) and blood glucose measurement can both be used for screening; the method does not appear to affect intervention effectiveness. Screening and recruitment is time-consuming, especially when targeting lower socioeconomic status and age under 45 years. The intervention intensity is more important for effectiveness than the mode of delivery. Moderate changes in several lifestyle habits lead to good intervention results. A minimum of 3-year follow-up seemed to be required to show a reduction in diabetes risk in high-risk individuals. In participants < 45 years, the achieved results in outcomes were less pronounced. The complementary review included 12 studies, with similar results regarding intervention targets and delivery modes, as well as clinical significance.
CONCLUSION
CONCLUSIONS
This narrative review highlighted several important aspects that subsequently guided the development of the Feel4Diabetes high-risk intervention. Research on diabetes prevention interventions targeted at younger adults or vulnerable population groups is still relatively scarce. Feel4Diabetes is a good example of a project aiming to fill this research gap.
TRIAL REGISTRATION
BACKGROUND
clinicaltrials.gov NCT02393872, registered 20th March 2015.
Identifiants
pubmed: 32164690
doi: 10.1186/s12902-019-0468-y
pii: 10.1186/s12902-019-0468-y
pmc: PMC7066732
doi:
Banques de données
ClinicalTrials.gov
['NCT02393872']
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
140Subventions
Organisme : The European Union's Horizon 2020 research and innovation program
ID : n° 643708
Investigateurs
Yannis Manios
(Y)
Greet Cardon
(G)
Jaana Lindström
(J)
Peter Schwarz
(P)
Konstantinos Makrilakis
(K)
Lieven Annemans
(L)
Ignacio Garamendi
(I)
Meropi Kontogianni
(M)
Odysseas Androutsos
(O)
Christina Mavrogianni
(C)
Konstantina Tsoutsoulopoulou
(K)
Christina Katsarou
(C)
Eva Karaglani
(E)
Irini Qira
(I)
Efstathios Skoufas
(E)
Konstantina Maragkopoulou
(K)
Antigone Tsiafitsa
(A)
Irini Sotiropoulou
(I)
Michalis Tsolakos
(M)
Effie Argyri
(E)
Mary Nikolaou
(M)
Eleni-Anna Vampouli
(EA)
Christina Filippou
(C)
Katerina Gatsiou
(K)
Efstratios Dimitriadis
(E)
Tiina Laatikainen
(T)
Katja Wikström
(K)
Jemina Kivelä
(J)
Päivi Valve
(P)
Esko Levälahti
(E)
Eeva Virtanen
(E)
Vicky Van Stappen
(V)
Nele Huys
(N)
Ruben Willems
(R)
Samyah Shadid
(S)
Ivonne Panchyrz
(I)
Maxi Holland
(M)
Patrick Timpel
(P)
Stavros Liatis
(S)
George Dafoulas
(G)
Christina-Paulina Lambrinou
(CP)
Angeliki Giannopoulou
(A)
Lydia Tsirigoti
(L)
Evi Fappa
(E)
Costas Anastasiou
(C)
Konstantina Zachari
(K)
Lala Rabemananjara
(L)
Maria Stella de Sabata
(MS)
Winne Ko
(W)
Luis Moreno
(L)
Fernando Civeira
(F)
Gloria Bueno
(G)
Pilar De Miguel-Etayo
(P)
Esther Mª Gonzalez-Gil
(EM)
Maria I Mesana
(MI)
Germán Vicente-Rodriguez
(G)
Gerardo Rodriguez
(G)
Lucia Baila-Rueda
(L)
Ana Cenarro
(A)
Estíbaliz Jarauta
(E)
Rocío Mateo-Gallego
(R)
Violeta Iotova
(V)
Tsvetalina Tankova
(T)
Natalia Usheva
(N)
Kaloyan Tsochev
(K)
Nevena Chakarova
(N)
Sonya Galcheva
(S)
Rumyana Dimova
(R)
Yana Bocheva
(Y)
Zhaneta Radkova
(Z)
Vanya Marinova
(V)
Yuliya Bazdarska
(Y)
Tanya Stefanova
(T)
Imre Rurik
(I)
Timea Ungvari
(T)
Zoltán Jancsó
(Z)
Anna Nánási
(A)
László Kolozsvári
(L)
Csilla Semánova
(C)
Remberto Martinez
(R)
Marcos Tong
(M)
Kaisla Joutsenniemi
(K)
Katrina Wendel-Mitoraj
(K)
Références
Lancet Diabetes Endocrinol. 2018 Jan;6(1):69-80
pubmed: 28847479
Trials. 2016 May 20;17(1):254
pubmed: 27206733
Diabetes Res Clin Pract. 2006 May;72(2):117-27
pubmed: 16297488
Diabetes Res Clin Pract. 2018 May;139:32-42
pubmed: 29476888
Matern Child Health J. 2018 Jun;22(6):803-811
pubmed: 29411251
Contemp Clin Trials. 2014 Jan;37(1):1-9
pubmed: 24177413
Ethn Dis. 2009 Spring;19(2):135-41
pubmed: 19537223
Diabetes Care. 2008 May;31(5):857-62
pubmed: 18252900
Clin Nutr. 2015 Aug;34(4):579-85
pubmed: 25262459
BMC Public Health. 2012 May 23;12:371
pubmed: 22621376
Diabetes Care. 2016 Jan;39(1):65-74
pubmed: 26657945
Diabetes Care. 2014 Nov;37(11):3009-15
pubmed: 25216506
Diabetes Educ. 2011 Jul-Aug;37(4):564-72
pubmed: 21690435
JAMA Intern Med. 2013 Jan 28;173(2):113-21
pubmed: 23229846
Am J Public Health. 2015 Nov;105(11):2328-34
pubmed: 26378828
Lancet Diabetes Endocrinol. 2013 Nov;1(3):191-8
pubmed: 24622367
BMC Public Health. 2009 Jun 30;9:213
pubmed: 19563685
Diabetes Care. 2011 Sep;34(9):1919-25
pubmed: 21775759
Implement Sci. 2018 Jul 18;13(1):97
pubmed: 30021592
Contemp Clin Trials. 2015 Nov;45(Pt B):320-327
pubmed: 26597415
Lancet. 2006 Nov 11;368(9548):1673-9
pubmed: 17098085
Control Clin Trials. 2002 Apr;23(2):157-71
pubmed: 11943442
Diabetes Res Clin Pract. 2001 Apr;52(1):29-43
pubmed: 11182214
Diabetologia. 2008 Nov;51(11):1971-9
pubmed: 18779946
Health Promot Pract. 2012 Sep;13(5):696-706
pubmed: 22773615
BMJ Open Diabetes Res Care. 2014 Apr 23;2(1):e000003
pubmed: 25452854
Diabet Med. 2017 Apr;34(4):563-568
pubmed: 27589695
PLoS One. 2013 Jul 22;8(7):e68605
pubmed: 23894322
PLoS One. 2016 Dec 9;11(12):e0167123
pubmed: 27935988
Diabetologia. 2006 Feb;49(2):289-97
pubmed: 16391903
Diabetes Res Clin Pract. 2014 Dec;106(3):e49-52
pubmed: 25467620
Diabetes Care. 2003 Apr;26(4):977-80
pubmed: 12663559
Diabetes Res Clin Pract. 2009 Oct;86(1):e1-5
pubmed: 19592125
BMJ Open. 2013 Feb 22;3(2):
pubmed: 23435795
Int J Epidemiol. 2012 Aug;41(4):1162-73
pubmed: 22736421
BMC Public Health. 2013 Nov 04;13:1035
pubmed: 24180316
PLoS Med. 2018 Jun 6;15(6):e1002575
pubmed: 29874236
BMC Fam Pract. 2012 Nov 16;13:109
pubmed: 23158830
Int J Epidemiol. 2012 Apr;41(2):377-85
pubmed: 21172932
Diabetologia. 2013 Feb;56(2):284-93
pubmed: 23093136
Diabetes Care. 2011 Jan;34(1):14-9
pubmed: 20929998
Diabetes Educ. 2012 Nov-Dec;38(6):811-21
pubmed: 23019237
Nutr Diabetes. 2013 Jun 24;3:e76
pubmed: 23797383
Diabetes Res Clin Pract. 2017 Jun;128:40-50
pubmed: 28437734
BMC Pregnancy Childbirth. 2014 Jan 15;14:21
pubmed: 24423410
Trials. 2011 Oct 06;12:220
pubmed: 21978409
Lancet Diabetes Endocrinol. 2014 Mar;2(3):218-27
pubmed: 24622752
Contemp Clin Trials. 2013 Mar;34(2):336-47
pubmed: 23354313
Am J Public Health. 2013 Jun;103(6):e38-46
pubmed: 23597377
Public Health Nutr. 2018 Dec;21(17):3281-3290
pubmed: 30207513
Int J Epidemiol. 2011 Jun;40(3):804-18
pubmed: 21335614
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
Diabetes Care. 2008 Oct;31(10):1949-54
pubmed: 18591401
Diabetes Care. 2016 Apr;39(4):525-31
pubmed: 26908915
Public Health Nurs. 2014 Jul-Aug;31(4):317-26
pubmed: 24251677
BMC Fam Pract. 2012 Aug 08;13:79
pubmed: 22873753
Postgrad Med J. 2005 Aug;81(958):486-90
pubmed: 16085737
Prim Care Diabetes. 2015 Apr;9(2):96-104
pubmed: 25128324
Diabetes Care. 2003 Dec;26(12):3230-6
pubmed: 14633807
Diabetes Care. 1997 Apr;20(4):537-44
pubmed: 9096977
Health Educ Behav. 2008 Aug;35(4):561-73
pubmed: 18456866
Am J Prev Med. 2017 Jun;52(6):788-797
pubmed: 28237635
Diabetes Care. 2003 Jan;26(1):36-47
pubmed: 12502656
BMC Public Health. 2009 Sep 16;9:342
pubmed: 19758428
Am J Public Health. 2012 Feb;102(2):336-42
pubmed: 22390448
Diabetes Res Clin Pract. 2013 Dec;102(3):158-66
pubmed: 24466598
Diabetes Educ. 2014 Mar-Apr;40(2):191-201
pubmed: 24464087
Diabetes Care. 2000 Apr;23 Suppl 2:B11-3
pubmed: 10860185
Diabetes Care. 2009 Jul;32(7):1143-6
pubmed: 19509014
Diabetes Res Clin Pract. 2005 Feb;67(2):152-62
pubmed: 15649575
Prim Care Diabetes. 2012 Jul;6(2):95-102
pubmed: 22306176
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Diabetes Educ. 2018 Apr;44(2):118-129
pubmed: 29514568
Arch Intern Med. 2011 Aug 8;171(15):1352-60
pubmed: 21824948
Arch Gynecol Obstet. 2014 Feb;289(2):319-27
pubmed: 23897066
Int J Behav Nutr Phys Act. 2013 Apr 19;10:47
pubmed: 23597082
Diabet Med. 2012 Aug;29(8):e223-31
pubmed: 22416789
Diabet Med. 2010 Apr;27(4):459-65
pubmed: 20536519
BMC Public Health. 2018 Jan 4;17(1):974
pubmed: 29298703
Lancet. 2008 May 24;371(9626):1783-9
pubmed: 18502303
Diabetes Res Clin Pract. 2018 Dec;146:85-92
pubmed: 30273708
J Community Health. 2016 Feb;41(1):87-96
pubmed: 26215167
BMJ. 2017 Jan 4;356:i6538
pubmed: 28052845
Transl Behav Med. 2014 Mar;4(1):18-25
pubmed: 24653773